Connection

Andrea Antinori to Aged

Back to Details
This is a "connection" page, showing publications Andrea Antinori has written about Aged.
Andrea Antinori
Connection Strength
0.174
Aged
  1. Age and subtle cognitive impairment are associated with long-term olfactory dysfunction after COVID-19 infection. J Am Geriatr Soc. 2021 Oct; 69(10):2778-2780.
    View in: PubMed
    Score: 0.008
  2. Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2-Related Encephalitis: The ENCOVID Multicenter Study. J Infect Dis. 2021 01 04; 223(1):28-37.
    View in: PubMed
    Score: 0.008
  3. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging. 2019 Jul; 46(8):1642-1651.
    View in: PubMed
    Score: 0.007
  4. Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease. Eur J Nucl Med Mol Imaging. 2018 12; 45(13):2387-2395.
    View in: PubMed
    Score: 0.007
  5. Brain-Area Specific White Matter Hyperintensities: Associations to Falls in Parkinson's Disease. J Parkinsons Dis. 2018; 8(3):455-462.
    View in: PubMed
    Score: 0.007
  6. Cognitive impairment in Glucocerebrosidase (GBA)-associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles. Mov Disord. 2017 Dec; 32(12):1780-1783.
    View in: PubMed
    Score: 0.007
  7. Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts. Mov Disord. 2017 Jul; 32(7):1025-1034.
    View in: PubMed
    Score: 0.006
  8. Association between cognitive impairment and urinary dysfunction in Parkinson's disease. J Neural Transm (Vienna). 2017 05; 124(5):543-550.
    View in: PubMed
    Score: 0.006
  9. Spontaneous ilio-psoas haematomas (IPHs): a warning for COVID-19 inpatients. Ann Med. 2021 12; 53(1):295-301.
    View in: PubMed
    Score: 0.004
  10. Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering. J Healthc Eng. 2021; 2021:5556207.
    View in: PubMed
    Score: 0.004
  11. Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia. Sci Rep. 2021 05 31; 11(1):11334.
    View in: PubMed
    Score: 0.004
  12. Hepatic Failure in COVID-19: Is Iron Overload the Dangerous Trigger? Cells. 2021 05 04; 10(5).
    View in: PubMed
    Score: 0.004
  13. The multidimensional prognostic index (MPI) for the prognostic stratification of older inpatients with COVID-19: A multicenter prospective observational cohort study. Arch Gerontol Geriatr. 2021 Jul-Aug; 95:104415.
    View in: PubMed
    Score: 0.004
  14. Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network. J Neurol. 2021 Oct; 268(10):3561-3568.
    View in: PubMed
    Score: 0.004
  15. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.004
  16. Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection. PLoS One. 2021; 16(2):e0247275.
    View in: PubMed
    Score: 0.004
  17. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int J Infect Dis. 2021 Apr; 105:49-53.
    View in: PubMed
    Score: 0.004
  18. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study. Thromb Haemost. 2021 Aug; 121(8):1054-1065.
    View in: PubMed
    Score: 0.004
  19. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
    View in: PubMed
    Score: 0.004
  20. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 11 09; 222(11):1807-1815.
    View in: PubMed
    Score: 0.004
  21. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
    View in: PubMed
    Score: 0.004
  22. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial". Trials. 2020 Oct 22; 21(1):875.
    View in: PubMed
    Score: 0.004
  23. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
    View in: PubMed
    Score: 0.004
  24. COVID-19 impact on consecutive neurological patients admitted to the emergency department. J Neurol Neurosurg Psychiatry. 2021 02; 92(2):218-220.
    View in: PubMed
    Score: 0.004
  25. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.004
  26. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutr Metab Cardiovasc Dis. 2020 10 30; 30(11):1899-1913.
    View in: PubMed
    Score: 0.004
  27. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy. Neurology. 2020 08 18; 95(7):e910-e920.
    View in: PubMed
    Score: 0.004
  28. Validation of the Italian version of the PSP Quality of Life questionnaire. Neurol Sci. 2019 Dec; 40(12):2587-2594.
    View in: PubMed
    Score: 0.004
  29. New resistance mutations to nucleoside reverse transcriptase inhibitors at codon 184 of HIV-1 reverse transcriptase (M184L and M184T). Chem Biol Drug Des. 2019 01; 93(1):50-59.
    View in: PubMed
    Score: 0.004
  30. A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patients. AIDS. 2018 07 17; 32(11):1431-1442.
    View in: PubMed
    Score: 0.003
  31. Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients. AIDS Behav. 2018 05; 22(5):1573-1583.
    View in: PubMed
    Score: 0.003
  32. Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease. Neurology. 2018 03 20; 90(12):e1029-e1037.
    View in: PubMed
    Score: 0.003
  33. Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study. J Alzheimers Dis. 2018; 61(3):907-912.
    View in: PubMed
    Score: 0.003
  34. Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy. Neurodegener Dis. 2017; 17(6):286-291.
    View in: PubMed
    Score: 0.003
  35. Altered brain metabolic connectivity at multiscale level in early Parkinson's disease. Sci Rep. 2017 06 26; 7(1):4256.
    View in: PubMed
    Score: 0.003
  36. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study. Lancet Gastroenterol Hepatol. 2017 06; 2(6):427-434.
    View in: PubMed
    Score: 0.003
  37. Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study. J Alzheimers Dis. 2017; 60(2):335-340.
    View in: PubMed
    Score: 0.003
  38. Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. Neurobiol Aging. 2015 Nov; 36(11):3108-3115.
    View in: PubMed
    Score: 0.003
  39. Understanding phenotype variability in frontotemporal lobar degeneration due to granulin mutation. Neurobiol Aging. 2014 May; 35(5):1206-11.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.